Nephroprotective role of resveratrol in renal ischemia-reperfusion injury: a preclinical study in Sprague-Dawley rats.
Apoptosis
Inflammation
Nephroprotection
Oxidative Stress
Renal Ischemia-Reperfusion Injury
Resveratrol
Journal
BMC pharmacology & toxicology
ISSN: 2050-6511
Titre abrégé: BMC Pharmacol Toxicol
Pays: England
ID NLM: 101590449
Informations de publication
Date de publication:
28 Oct 2024
28 Oct 2024
Historique:
received:
11
08
2024
accepted:
22
10
2024
medline:
29
10
2024
pubmed:
29
10
2024
entrez:
29
10
2024
Statut:
epublish
Résumé
Renal ischemia-reperfusion injury (IRI) is a significant contributor to renal dysfunction, acute kidney injury (AKI), and associated morbidity and mortality. Resveratrol, a polyphenol and phytoalexin, is known for its anti-inflammatory, antioxidant, and anti-cancer properties. This study investigates the nephroprotective potential of resveratrol in a rat model of renal IRI. Twenty-eight male Sprague-Dawley rats were divided into four groups: Sham, IRI, DMSO, and Resveratrol. The Sham group underwent identical procedures without renal pedicle clamping, while the IRI group experienced 30 min of ischemia followed by 2 h of reperfusion. The DMSO group received dimethyl sulfoxide (DMSO) intraperitoneally 30 min before ischemia, and the Resveratrol group received 30 mg/kg resveratrol intraperitoneally 30 min before ischemia. Biochemical parameters (Urea, creatinine, IL-1β, NF-κβ, SOD, GSH, Bcl-2, and caspase-3) and histopathological changes were assessed. IRI caused a substantial increase in serum creatinine, Urea, IL-1β, NF-κβ, and caspase-3 levels, while simultaneously decreasing SOD, GSH, and Bcl-2 levels. Resveratrol treatment mitigated these effects by lowering inflammatory and apoptotic markers, enhancing antioxidant defenses, and improving histological outcomes. Resveratrol demonstrates significant nephroprotective effects in renal IRI, primarily through its antioxidant, anti-inflammatory, and anti-apoptotic properties.
Sections du résumé
BACKGROUND
BACKGROUND
Renal ischemia-reperfusion injury (IRI) is a significant contributor to renal dysfunction, acute kidney injury (AKI), and associated morbidity and mortality. Resveratrol, a polyphenol and phytoalexin, is known for its anti-inflammatory, antioxidant, and anti-cancer properties. This study investigates the nephroprotective potential of resveratrol in a rat model of renal IRI.
MATERIALS AND METHODS
METHODS
Twenty-eight male Sprague-Dawley rats were divided into four groups: Sham, IRI, DMSO, and Resveratrol. The Sham group underwent identical procedures without renal pedicle clamping, while the IRI group experienced 30 min of ischemia followed by 2 h of reperfusion. The DMSO group received dimethyl sulfoxide (DMSO) intraperitoneally 30 min before ischemia, and the Resveratrol group received 30 mg/kg resveratrol intraperitoneally 30 min before ischemia. Biochemical parameters (Urea, creatinine, IL-1β, NF-κβ, SOD, GSH, Bcl-2, and caspase-3) and histopathological changes were assessed.
RESULTS
RESULTS
IRI caused a substantial increase in serum creatinine, Urea, IL-1β, NF-κβ, and caspase-3 levels, while simultaneously decreasing SOD, GSH, and Bcl-2 levels. Resveratrol treatment mitigated these effects by lowering inflammatory and apoptotic markers, enhancing antioxidant defenses, and improving histological outcomes.
CONCLUSION
CONCLUSIONS
Resveratrol demonstrates significant nephroprotective effects in renal IRI, primarily through its antioxidant, anti-inflammatory, and anti-apoptotic properties.
Identifiants
pubmed: 39468702
doi: 10.1186/s40360-024-00809-8
pii: 10.1186/s40360-024-00809-8
doi:
Substances chimiques
Resveratrol
Q369O8926L
Antioxidants
0
Caspase 3
EC 3.4.22.-
Interleukin-1beta
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
82Informations de copyright
© 2024. The Author(s).
Références
Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7:189–200.
doi: 10.1038/nrneph.2011.16
pubmed: 21364518
Kerrigan CL, Stotland MA. Ischemia reperfusion injury: a review. Microsurgery. 1993;14:165–75.
doi: 10.1002/micr.1920140307
pubmed: 8479314
Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001;94:1133–8.
doi: 10.1097/00000542-200106000-00030
pubmed: 11465607
Ponticelli C. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol Dial Transpl. 2014;29:1134–40.
doi: 10.1093/ndt/gft488
Audard V, Moutereau S, Vandemelebrouck G, Habibi A, Khellaf M, Grimbert P, Levy Y, Loric S, Renaud B, Lang P, et al. First evidence of subclinical renal tubular injury during sickle-cell crisis. Orphanet J Rare Dis. 2014;9:67.
doi: 10.1186/1750-1172-9-67
pubmed: 24779676
pmcid: 4006801
Rojas-Morales P, Leon-Contreras JC, Aparicio-Trejo OE, Reyes-Ocampo JG, Medina-Campos ON, Jimenez-Osorio AS, Gonzalez-Reyes S, Marquina-Castillo B, Hernandez-Pando R, Barrera-Oviedo D, et al. Fasting reduces oxidative stress, mitochondrial dysfunction and fibrosis induced by renal ischemia-reperfusion injury. Free Radic Biol Med. 2019;135:60–7.
doi: 10.1016/j.freeradbiomed.2019.02.018
pubmed: 30818054
Awad AS, Rouse M, Huang L, Vergis AL, Reutershan J, Cathro HP, Linden J, Okusa MD. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int. 2009;75:689–98.
doi: 10.1038/ki.2008.648
pubmed: 19129795
pmcid: 2656389
Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease. Nutrients 2017;9(7):718.
Jansen MP, Emal D, Teske GJ, Dessing MC, Florquin S, Roelofs JJ. Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. Kidney Int. 2017;91:352–64.
doi: 10.1016/j.kint.2016.08.006
pubmed: 27692564
Park S, Lee S, Lee A, Paek JH, Chin HJ, Na KY, Chae DW, Kim S. Awareness, incidence and clinical significance of acute kidney injury after non-general anesthesia: A retrospective cohort study. Med (Baltim). 2018;97:e12014.
doi: 10.1097/MD.0000000000012014
Nakao S, Mabuchi M, Wang S, Kogure Y, Shimizu T, Noguchi K, Tanaka A, Dai Y. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor. Bioorg Med Chem Lett. 2017;27:3167–72.
doi: 10.1016/j.bmcl.2017.05.025
pubmed: 28576617
Gobec M, Tomasic T, Markovic T, Mlinaric-Rascan I, Dolenc MS, Jakopin Z. Antioxidant and anti-inflammatory properties of 1,2,4-oxadiazole analogs of resveratrol. Chem Biol Interact. 2015;240:200–7.
doi: 10.1016/j.cbi.2015.08.018
pubmed: 26335192
Gerszon J, Rodacka A, Puchała M. Antioxidant Properties of Resveratrol and its Protective Effects in Neurodegenerative Diseases. Med J Cell Biology. 2014;4:97–117.
Wang TT, Schoene NW, Kim YS, Mizuno CS, Rimando AM. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Mol Nutr Food Res. 2010;54:335–44.
doi: 10.1002/mnfr.200900143
pubmed: 20077416
Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010;70:9003–11.
doi: 10.1158/0008-5472.CAN-10-2364
pubmed: 20935227
pmcid: 2982884
Gao Y, Fu R, Wang J, Yang X, Wen L, Feng J. Resveratrol mitigates the oxidative stress mediated by hypoxic-ischemic brain injury in neonatal rats via Nrf2/HO-1 pathway. Pharm Biol. 2018;56:440–9.
doi: 10.1080/13880209.2018.1502326
pubmed: 30460866
pmcid: 6249550
Xue R, Gao S, Zhang Y, Cui X, Mo W, Xu J, Yao M. A meta-analysis of resveratrol protects against cerebral ischemia/reperfusion injury: evidence from rats studies and insight into molecular mechanisms. Front Pharmacol 2022;13:988836.
Zhang M, Li W, Yu L, Wu S. The Suppressive Effect of Resveratrol on HIF-1α and VEGF Expression after Warm Ischemia and Reperfusion in Rat Liver. PLoS ONE. 2014;9:e109589.
doi: 10.1371/journal.pone.0109589
pubmed: 25295523
pmcid: 4190191
Guvenc M, Cellat M, Uyar A, Ozkan H, Gokcek I, Isler CT, Yakan A. Nobiletin Protects from Renal Ischemia-Reperfusion Injury in Rats by Suppressing Inflammatory Cytokines and Regulating iNOS-eNOS Expressions. Inflammation. 2020;43:336–46.
doi: 10.1007/s10753-019-01123-w
pubmed: 31705353
Nezamoleslami S, Sheibani M, Jahanshahi F, Mumtaz F, Abbasi A, Dehpour AR. Protective effect of dapsone against renal ischemia-reperfusion injury in rat. Immunopharmacol Immunotoxicol. 2020;42:272–9.
doi: 10.1080/08923973.2020.1755308
pubmed: 32321337
Tiba AT, Qassam H, Hadi NR. Semaglutide in renal ischemia-reperfusion injury in mice. J Med Life. 2023;16:317–24.
doi: 10.25122/jml-2022-0291
pubmed: 36937464
pmcid: 10015556
Li J, Li L, Wang S, Zhang C, Zheng L, Jia Y, Xu M, Zhu T, Zhang Y, Rong R. Resveratrol Alleviates Inflammatory Responses and Oxidative Stress in Rat Kidney Ischemia-Reperfusion Injury and H2O2-Induced NRK-52E Cells via the Nrf2/TLR4/NF-κB Pathway. Cell Physiol Biochem. 2018;45:1677–89.
doi: 10.1159/000487735
pubmed: 29490296
Xiao Z, Chen C, Meng T, Zhang W, Zhou Q. Resveratrol attenuates renal injury and fibrosis by inhibiting transforming growth factor-beta pathway on matrix metalloproteinase 7. Exp Biol Med (Maywood). 2016;241:140–6.
doi: 10.1177/1535370215598401
pubmed: 26316584
Stroo I, Stokman G, Teske GJD, Raven A, Butter LM, Florquin S, Leemans JC. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol. 2010;22:433–42.
doi: 10.1093/intimm/dxq025
pubmed: 20410256
pmcid: 2877810
Li Y, Hou D, Chen X, Zhu J, Zhang R, Sun W, Li P, Tian Y, Kong X. Hydralazine protects against renal ischemia-reperfusion injury in rats. Eur J Pharmacol. 2019;843:199–209.
doi: 10.1016/j.ejphar.2018.11.015
pubmed: 30472201
Nezamoleslami S, Sheibani M, Dehpour AR, Mobasheran P, Shafaroodi H. Glatiramer acetate attenuates renal ischemia reperfusion injury in rat model. Exp Mol Pathol. 2020;112:104329.
doi: 10.1016/j.yexmp.2019.104329
pubmed: 31697931
Shen Y, Qiu T, Liu XH, Zhang L, Wang ZS, Zhou JQ. Renal ischemia-reperfusion injury attenuated by splenic ischemic preconditioning. Eur Rev Med Pharmacol Sci. 2018;22:2134–42.
pubmed: 29687873
Wang M, Weng X, Chen H, Chen Z, Liu X. Resveratrol inhibits TNF-α-induced inflammation to protect against renal ischemia/reperfusion injury in diabetic rats. Acta Cirúrgica Brasileira 2020;35(5):e202000506.
Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Ren Inj Prev. 2015;4:20–7.
pubmed: 26060833
pmcid: 4459724
Chander V, Chopra K. Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats. Arch Med Res. 2006;37:19–26.
doi: 10.1016/j.arcmed.2005.05.018
pubmed: 16314181
Sener G, Tugtepe H, Yuksel M, Cetinel S, Gedik N, Yegen BC. Resveratrol improves ischemia/reperfusion-induced oxidative renal injury in rats. Arch Med Res. 2006;37:822–9.
doi: 10.1016/j.arcmed.2006.04.003
pubmed: 16971220
Amini N, Badavi M, Goudarzi M. A new combination of naringin and trimetazidine protect kidney Mitochondria dysfunction induced by renal Ischemia / Reperfusion injury in rat. Brazilian J Pharm Sci 2022;58.
Khader A, Yang WL, Kuncewitch M, Prince JM, Marambaud P, Nicastro J, Coppa GF, Wang P. Novel resveratrol analogues attenuate renal ischemic injury in rats. J Surg Res. 2015;193:807–15.
doi: 10.1016/j.jss.2014.08.015
pubmed: 25214260
Xu Y, Zhang B, Xie D, Hu Y, Li HL, Zhong LL, Wang HW, Jiang W, Ke ZP, Zheng DH. Nanoparticle-mediated dual delivery of resveratrol and DAP5 ameliorates kidney ischemia/reperfusion injury by inhibiting cell apoptosis and inflammation. Oncotarget. 2017;8:39547–58.
doi: 10.18632/oncotarget.17135
pubmed: 28465474
pmcid: 5503631
Ye Q, Zhu YI, Ye S, Liu H, She X, Niu Y, Ming Y. Gypenoside attenuates renal ischemia/reperfusion injury in mice by inhibition of ERK signaling. Exp Ther Med. 2016;11:1499–505.
doi: 10.3892/etm.2016.3034
pubmed: 27073472
pmcid: 4812469
Alsaaty EH, Janabi AM. Moexipril Improves Renal Ischemia/Reperfusion Injury in Adult Male Rats. J Contemp Med Sci 2024;10(1):25–30.
Alaasam ER, Janabi AM. Erythropoietin protects against renal ischemia/reperfusion injury in rats via inhibition of oxidative stress, inflammation and apoptosis. J Contemp Med Sci 2023;21(10):3453.